Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Pollock

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Anaesthesia and Intensive Care|August 1, 1997
Management of malignant hyperthermia susceptible parturientsN A Pollock, E E Langton
British Journal of Anaesthesia|May 24, 2000
Malignant hyperthermia in infancy and identification of novel RYR1 mutationD Chamley, N A Pollock, K M Stowell, et al.
Anaesthesia and Intensive Care|September 16, 2017
Administration of anaesthetic triggering agents to patients tested malignant hyperthermia normal and their relatives in New Zealand: an updateD Frei, K M Stowell, E E Langton, et al.
Anaesthesia and Intensive Care|November 16, 2017
Evidence of malignant hyperthermia in patients administered triggering agents before malignant hyperthermia susceptibility identified: missed opportunities prior to diagnosisT Y Chan, T F Bulger, K M Stowell, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Anaesthesia and Intensive Care|August 1, 1997
Management of malignant hyperthermia susceptible parturientsN A Pollock, E E Langton
British Journal of Anaesthesia|May 24, 2000
Malignant hyperthermia in infancy and identification of novel RYR1 mutationD Chamley, N A Pollock, K M Stowell, et al.
Anaesthesia and Intensive Care|September 16, 2017
Administration of anaesthetic triggering agents to patients tested malignant hyperthermia normal and their relatives in New Zealand: an updateD Frei, K M Stowell, E E Langton, et al.
Anaesthesia and Intensive Care|November 16, 2017
Evidence of malignant hyperthermia in patients administered triggering agents before malignant hyperthermia susceptibility identified: missed opportunities prior to diagnosisT Y Chan, T F Bulger, K M Stowell, et al.
Pageof 1